INSMED INC Number of Reportable Segments
INSMED INC (INSM) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-06
- INSMED INC number of reportable segments for the quarter ending 2013-03-31 was 1.00 item.
- INSMED INC number of reportable segments for fiscal 2016 was 1.00 item, a 0.00% change from fiscal 2015.
- INSMED INC number of reportable segments for fiscal 2015 was 1.00 item, a 0.00% change from fiscal 2014.
- INSMED INC number of reportable segments for fiscal 2014 was 1.00 item, a 0.00% change from fiscal 2013.
- INSMED INC number of reportable segments for fiscal 2013 was 1.00 item.
item
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2016-12-31 | 1.00 item 10-K · filed 2017-02-23 | |||
| 2015-12-31 | 1.00 item 10-K · filed 2016-02-25 | |||
| 2014-12-31 | 1.00 item 10-K · filed 2015-02-27 | |||
| 2013-12-31 | 1.00 item 10-K · filed 2014-03-06 | |||
| 2013-09-30 | 1.00 item 10-Q · filed 2013-11-05 | |||
| 2013-06-30 | 1.00 item 10-Q · filed 2013-08-06 | |||
| 2013-03-31 | 1.00 item 10-Q · filed 2013-05-07 |
pure
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2012-12-31 | 100.00% 10-K · filed 2013-03-18 |
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-19 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-20 | |||
| 2023-12-31 | 1.00 segment 10-K · filed 2024-02-22 | |||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-23 | |||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-17 | |||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-02-25 | |||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-02-25 | |||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-02-22 | |||
| 2017-12-31 | 1.00 segment 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |